Alimera Sciences To Release Fourth Quarter And Fiscal Year 2013 Financial Results

[PR Newswire] – ATLANTA, Feb. 20, 2014 /PRNewswire/ — Alimera Sciences, Inc. (NASDAQ: ALIM) (Alimera), a biopharmaceutical company that specializes in the research, development and commercialization of prescription … more

View todays social media effects on ALIM

View the latest stocks trending across Twitter. Click to view dashboard

See who Alimera is hiring next, click here to view